Short description
Broncus Technologies is a medical technology company developing minimally-invasive medical devices for emphysema and other lung diseases.
Description
Broncus Technologies is a medical technology company focused on developing minimally-invasive medical devices for emphysema and other lung diseases. Broncus is investigating the Exhale emphysema product line to perform our patented treatment method called Airway Bypass. Airway Bypass could be the first minimally-invasive procedure for the treatment of homogeneous, or diffuse, emphysema, which constitutes the majority of the emphysema patient population.
Broncus is currently enrolling patients worldwide in our pivotal EASE Trial investigating a treatment of severe homogeneous emphysema.
Broncus is located in Mountain View, CA (San Francisco Bay area).
Broncus International is located in Nyon, Switzerland.
Last funding
Noaccessforu
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Mountain View, California, United States, North America
Founded on
January 1, 1997
Exited on
September 24, 2021
Went public on
September 24, 2021
Stock symbol
2216
Non-profit?
No
Acquired?
No
Employees count
51-100
Revenue range
$1230 - 4560
Sign in for full access
Investors
Noaccess, Noaccess, Absolutely Noaccess, Absolutely Noaccess, Uh Ohhhh, Noway Youcantaccess, Noaccess, Absolutely Noaccess, Cannot Access, Cannot Access, Nopepepe, Noway Youcantaccess, Cannot Access, Cannot Access, Blurry Noaccess, Cannot Access, Noaccessforu, Cannot Access, Cannot Access, Noway Youcantaccess, Noway Youcantaccess, Noaccess, Cannot Access, Absolutely Noaccess, Uh Ohhhh, Noaccess, Noway Youcantaccess, Uh Ohhhh, Noaccess, Absolutely Noaccess
Sign in for full access
Founders
Glen French